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Summary
Objective: Until the current molecular genetic investigations, all available data concerning the genetic predisposition to Heberden’s nodes are
based on a single investigation by Stecher in the 1940s. There is controversy in the literature about the correlation between Heberden’s nodes
and generalized osteoarthritis (GOA). Our own epidemiological and clinical investigations support this correlation. Therefore, the question
arises as to whether the remarkable inheritance described by Stecher is correct and whether Heberden’s nodes can indeed be used as a ge-
netic marker for GOA.
Methods: From our clinical trial on 106 patients with Heberden’s arthritis, we could identify 88 families from index cases. Altogether, we in-
cluded 931 family members over a maximum of four generations. First of all, the genealogical trees of the families were established. Subse-
quently, we examined the patients’ hands in respect of Heberden’s nodes and completed the genealogical trees during home visits.
Results: In the 88 families analyzed, 152 patients with manifest Heberden’s arthritis were listed (26 males, 126 females). The genealogical
analysis of 156 descendants (74 males, 82 females) of 93 patients with Heberden’s nodes suggests autosomal dominant inheritance. In
view of the age-related manifestation and age pattern of the descendants, we postulate a heterozygous manifestation for women (dominant
gene action) and only a homozygous manifestation for men (recessive gene action).
Conclusions: The genealogic analysis does not contrast with the quite remarkable inheritance described by Stecher but rather supports the
hypothesis that manifestation is dominant in females and recessive in males. From our point of view, this heredity does not contradict latest
genetic assays which show the possibility of genetic defects causing the hereditary osteoarthritis (OA).
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Heberden’s arthritis has an exceptional position amongst
the various types of primary osteoarthritis (OA) of the
hand. The peculiar predilection for the distal interphalangeal
joints facilitates diagnosis and differentiation from inﬂamma-
tory arthropathies1e3. Heberden’s nodes are a characteristic
sign. Both osteophytes in Heberden’s arthritis and hyalur-
onic acid cysts which are observed in young patients are
described in the literature as Heberden’s nodes4e7. We
only considered patients with manifest osteophytes in our
investigation.
A particular strain on these joints could not be identiﬁed
as an etiological factor. Merely an increased stress on the
ﬁngertip due to traction of the long ﬂexion and extension
tendons has been discussed8,9. The superﬁcial ﬂexion ten-
dons do most work only when the ﬁst is closed. Further-
more, the joint surface is smaller than that of the proximal
interphalangeal (PIP) joints, so that the impact is greater.
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2005.42Some authors see the cause in an interaction of genetic,
mechanical and biomechanical mechanisms10,11.
It is of particular importance to be aware that the
correlation between Heberden’s nodes and generalized
osteoarthritis (GOA) is controversial in the literature. Con-
tradictions have resulted in particular from the different def-
initions of the clinical features of GOA. A few authors have
investigated the smaller hand and foot joints only, whereas
others included hip and knee joints and also integrated the
spine. Whether and if so in which combination the single
joints are affected is therefore appraised differently in the
literature12e25.
In our own epidemiological study (on 1997 persons) and
clinical/radiological analysis (on 106 patients), we were able
to demonstrate a signiﬁcant and close correlation between
GOA and Heberden’s nodes26e28. We detected explicit ev-
idence that a predisposition to GOA is present in patients
with polyarthritis of the ﬁngers. For numerous functional
and radiological degenerative parameters of hip, knee,
shoulder and ﬁnger joints as well as of the cervical, thoracic
and lumbar spine, a preponderance in patients with Heber-
den’s nodes as compared to various control groups was
discovered. The maximum frequency was approximately
30% depending on the population chosen. The presence
of a generalized disease was particularly clear when multi-
ple levels of ﬁnger joints were affected (Heberden’s and
Bouchard’s nodes, rhizarthritis).3
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about the genetic predisposition to Heberden’s arthritis
were based on data from investigations that Stecher had
performed in the 1940s29e33. These statements are cited
until the 1970s and 1980s. We found references to second-
ary papers only in the 1990s and later.
Based on an examination of 74 families with incidence of
Heberden’s nodes, on the basis of genealogical and epide-
miological data Stecher found that female trait carriers were
heterozygous (dominant inheritance) and male trait carriers
were homozygous (recessive inheritance)29e33. The fre-
quency of manifestation was 1% in women in the ﬁfth de-
cade and 30% in the seventh decade of life. On the other
hand, the incidence is seldom more than 3% in the male
population. Based on the maximum frequency of 30% index
cases amongst women, we assume that there are 30% ho-
mozygous and heterozygous women (HH and Hh) aged 70
years and older. On the basis of the HardyeWeinberg law,
the incidence of heterozygosity is therefore about 27%34,35.
It is well known that the manifestation of monogenic auto-
somal traits is inﬂuenced by gender. However, manifesta-
tions that are only homozygous in one gender and
heterozygous in the other are rare. Therefore, it is remark-
able that Stecher’s conclusions were not checked by other
authors.
In the current literature in analyses of 337 families, a sig-
niﬁcant genetic contribution to OA with evidence for a major
recessive gene and a multifactorial component was
found36. Others described epidemiological evidence for
a strong hereditary component in hand OA37. The genetics
of primary idiopathic OA are likely to be complex since mul-
tiple susceptibility loci have been identiﬁed from genome-
wide scans38. In classic twin studies, an inﬂuence of genetic
factors amounting to between 39% and 70% was seen39.
These estimations suggest that half the variation in suscep-
tibility to disease in the population is explained by genetic
factors. Investigation of different autoantibodies and immu-
noglobulins revealed an involvement of immune processes
in the pathogenesis of GOA40. Also a new hypothesis that
systemic factors including altered lipid metabolism might
explain the diversity of physiological changes in GOA was
postulated41.
To summarize, the aim of the study was to reexamine
Stecher’s results from the 1940s because his investigation
on 74 families was the only basis anywhere in the world
for assuming a genetic background of Heberden’s nodes
until the current molecular genetic investigations. The spe-
cial interest consists in the close correlation between He-
berden’s nodes and GOA. The same genetic modalities
must also apply to GOA.
Materials and methods
In our clinical trials, we subjected 106 patients with He-
berden’s nodes (the clinical criterion ‘‘Heberden’s nodes’’
was considered to be fulﬁlled if one or more joints showed
clinically manifest Heberden’s nodes) and 109 persons of
a control group not manifesting Heberden’s nodes to a clin-
ical and radiological assessment of the hip, knee, shoulder
and ﬁnger joints. Furthermore, the cervical, thoracic and
lumbar spine were examined by clinical and radiological cri-
teria26,28. The essential aim was to clarify whether there is
a correlation between Heberden’s nodes and GOA.
In the group suffering from Heberden’s nodes, we could
make a genetic analysis of the families of 88 patients. We
limited the trial to four generations and could gather 931sibs. Based on the known index cases, we established
the genealogical trees. In the following step, we examined
the hands of the relatives in terms of Heberden’s nodes dur-
ing home visits to establish the family trees more precisely.
Afterwards, performing histological analyses in another
study, we could conﬁrm that the clinical trait ‘‘Heberden’s
nodes’’ allows a reliable diagnosis27.
From the 931 sibs, 116 could be examined. For the re-
maining 815 people, information was only available from
the history.
Each family history was taken in the form of a pedigree
and familial concentration was investigated. The statistical
methods used are speciﬁed in the Results section.
Results
Amongst 931 sibs in 88 families, we registered 152 prop-
ositi with Heberden’s nodes in a ratio of men to women of
1:4.8 (26 men, 126 women). A familial concentration was
demonstrated in 43 families; the trait was sporadic in 45
families.
For 93 propositi, we had relevant data and ﬁndings for
156 (Fig. 1) descendants (74 boys and 82 girls).
When only the descendants of propositi with familial man-
ifestation were assessed, nine out of 47 boys and 32 out of
56 girls were affected. The preponderance of affected vs
nonaffected girls (32:24) is based on a differential selection
of the familial cases. This is why affected propositi of fami-
lies with sporadic traits having only healthy children must be
added (sib correction according to Weinberg)34,35. Other-
wise, the heterozygous but phenotypic healthy children (re-
cessive heredity) could not be surveyed. After correction, 32
out of 82 girls and nine out of 74 boys were affected.
The categorization of descendants depending on the
gender of affected parents is especially interesting. Se-
venty-seven female patients have 31 affected and 44
Fig. 1. Fictitious clan table of 93 index cases with 156 descendants:
¤ total,,male, andB female. White signs: healthy till now. Black
signs: manifest affected.
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does not differ signiﬁcantly (c2¼ 1.13) from the theoretically
expected result of 50:50 (in dominant heredity, the trait is
passed to 50% of the descendants, Fig. 2). At the time of
investigation, the average age of the affected daughters
of female trait carriers was 58.1 years (33e74), and the av-
erage age of the daughters who were not yet affected was
35.6 years (11e58). Therefore it seems that some of the not
yet affected have not reached the age of manifestation so
that the number of daughters affected will still rise (Fig. 3).
The result of our trial therefore implies a dominant inheri-
tance with heterozygous manifestation.
Eight sons of six of the 77 affected women are also af-
fected. Assuming a homozygous manifestation in men, at
least six of the 77 fathers must be heterozygous (minimum
frequency of heterozygosity, 0.078¼ 7.8%). However, ac-
cording to Stecher the frequency of heterozygosity is
0.27. In our epidemiological investigation, we found the
same frequency as Stecher26.
From 16 male patients who had 17 daughters, one has
been affected until now. Out of 11 sons, also one was af-
fected (Fig. 1). Supposing that this son was homozygous,
the mother must have been heterozygous and therefore
she must have had Heberden’s arthritis. Unfortunately, we
do not have relevant data to conﬁrm this since the mother
died early, possibly before disease manifestation. There-
fore, we can only assume that at least one of the 16
mothers must have been heterozygous (heterozygosity fre-
quency, 0.063¼ 6.3%).
If heterozygosity in females means illness, all daughters
of the male patients must have been affected, because
one pathological gene would pass to each daughter from
the homozygous fathers. As the nonaffected daughters
had a median age of 30 years (13e51) and because of
the age distribution (Fig. 3), we assume that the age of man-
ifestation was not yet reached at the time of our
investigation.
Discussion
Considering the age distribution pattern of the patients in-
vestigated, our own genealogic survey is not inconsistent
with Stecher’s statement that Heberden’s arthritis has auto-
somal monogenic inheritance in our data compilation for
many families over three or four generations. In females,
the disease is manifested in the heterozygous situation in
accordance with a dominant heredity. In males, the trait is
homozygous and shows a recessive heredity.
Father
h
H Hh
Mother
h hh
h
Hh
hh
1:1
Fig. 2. Combination square in monomeric inheritance for heterozy-
gousehomozygous parents. H¼ gene for trait Heberden’s arthritis
and h¼ normal gene.Stecher’s conclusion that Heberden’s nodes have an au-
tosomal sex-linked heredity may entail a terminological er-
ror. A sex-linked heredity postulates the localization of the
affected gene on the X chromosome, but he evidently
meant a manifestation depending on gender, which is
also our conclusion.
Dominance and recessiveness are phenotypic character-
istics, which are inﬂuenced by the genotype and environ-
ment39,42. That is why the genetics of Heberden’s nodes
apparently contradict Mendelian inheritance patterns. This
fact corresponds with notions of physiological genetics29.
For instance, concentration of any threshold substance
(e.g., hormonal concentrations) responsible for release or
suppress any reaction can be changed in such a way that
an autosomally inherited trait can be dominant in one sex
or recessive in the opposite sex.
Molecular biological investigations showed that genetic
defects can be the cause of hereditary OA43. Appropriate
tests will therefore allow early detection of predisposition
to OA.
Various surveys suggest but do not prove that mainly a
mutation in a gene of the cartilaginous matrix (COL 2 A1)
causes the manifestation of Heberden’s arthritis or
GOA44e48. On the other hand, some authors did not ﬁnd
any correlation between Heberden’s nodes or GOA and
the three cartilaginous matrix genes investigated (COL 2
A1 for codiﬁcation of type II collagen; CRTL 1 for codiﬁca-
tion of link protein and CRTM responsible for cartilaginous
matrix protein)22.
Collagens are formed from various procollagens with dif-
ferent structures. Changes in one collagen (structure, stabil-
ity, and degradation) are possible when only one part of the
corresponding procollagen is disturbed, i.e., in a heterozy-
gous manner. This explains the dominant inheritance. If
long-term processes are involved, for example in stability
or degradation, it is possible that the hormonal situation
has an effect and a recessive inheritance can be simulated.
The detection of a mutation in a procollagen (e.g., COL 2
A1) does not contradict the postulated inheritance.
Other studies also provide some information on the
genetic background. They discovered considerable
0
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Index case mother, daughter inconspicuous
Index case mother, daughter affected
Index case father, daughter inconspicuous
Fig. 3. Age pattern of the daughters of the index cases.
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nous metabolites (the metalloproteinases stromelysin and
aggressin) in GOA and localized osteoarthritis (LOA)49.
They also found a higher level of various metalloprotei-
nases in GOA than in knee OA and concluded that they
may be an indicator for whole-joint degeneration50. Other
researchers described a correlation between erosive hand
OA and a genomic region51. The hypothesis of a major
gene effect in heritability of hand OA was also supported52.
Some other recent studies have demonstrated a genetic ef-
fect on interindividual variation of age adjusted OA of the
hands, knees, hip joints, spine53e58 and the GOA59.
Our calculation of the frequency of heterozygosity of
6.3e7.8% is a minimum and still lies clearly below Stecher’s
declaration of 27%29. Possibly it is due to incomplete man-
ifestation or the too small size of the sample. Furthermore,
the incidence of 27% was not calculated on the basis of
a survey on sibs but rather on the occurrence of clinical
symptoms in a sample assuming the inheritance speciﬁed
above and calculating it according to the HardyeWeinberg
law. Using this method in our epidemiological investigation,
the outcome is the same as that declared by Stecher, if
a maximum prevalence of 30% is used26,29.
To summarize, our genealogical studies are compatible
with the heritability described by Stecher. The investigation
corroborates the idea of a dominant manifestation in fe-
males and recessive heredity in males. The strong correla-
tion between Heberden’s nodes and GOA described in the
literature and in our own epidemiological and clinical inves-
tigations indicates that this pattern of heredity applies to
GOA, so that Heberden’s nodes can be used as a genetic
marker for GOA.
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